Scholarlink

<p>PCSK5 (proprotein convertase subtilisin/kexin 5) is essential for heart development. However, its role in myocardial infarction (MI) remains unexplored. In this study, we found that the plasma levels of PCSK5 were elevated in MI patients and exhibited potential in predicting cardiac function improvement. PCSK5 expression was upregulated in cardiac endothelial cells (ECs) of MI patients. <i>Pcsk5</i> deficiency in ECs impaired angiogenesis and cardiac recovery post-MI, and delayed tissue repair following hindlimb ischemic injury in male mice. In contrast, the endothelial-specific <i>Pcsk5</i> delivery enhanced angiogenesis and cardiac function post-MI. Mechanistically, PCSK5 directly cleaved VEGFA, activating its signaling and promoting angiogenic activity. The residues Arg158 and Asn164 of PCSK5 were crucial for its function. Semaglutide increased vascular densities and cardiac function post-MI, partially through EC-derived <i>Pcsk5</i> in male mice. This study identified PCSK5 as a pro-angiogenic factor secreted by ECs, with the potential to become a therapeutic target for ischemic diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

PCSK5 promotes angiogenesis and cardiac repair after myocardial infarction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月3日

查看全文
  • Jieyu Guo,
  • Siyu Ma,
  • Jinghua Ma,
  • Ming Liu,
  • Fei Ge,
  • Xinhong Wang,
  • Jiayi Lin,
  • Nan Jiang,
  • Xiaoke Lin,
  • Zhipeng Lian,
  • Zheng Zuo,
  • Liliang Li,
  • Genmao Cao,
  • Yongbo Li,
  • Xiangxiang Wei,
  • Xianlong NG,
  • Xiuling Zhi,
  • Elena Osto,
  • Yuxiang Dai,
  • Jun Li,
  • Lixin Wang,
  • Hong Jiang,
  • Dan Meng

摘要

PCSK5 (proprotein convertase subtilisin/kexin 5) is essential for heart development. However, its role in myocardial infarction (MI) remains unexplored. In this study, we found that the plasma levels of PCSK5 were elevated in MI patients and exhibited potential in predicting cardiac function improvement. PCSK5 expression was upregulated in cardiac endothelial cells (ECs) of MI patients. Pcsk5 deficiency in ECs impaired angiogenesis and cardiac recovery post-MI, and delayed tissue repair following hindlimb ischemic injury in male mice. In contrast, the endothelial-specific Pcsk5 delivery enhanced angiogenesis and cardiac function post-MI. Mechanistically, PCSK5 directly cleaved VEGFA, activating its signaling and promoting angiogenic activity. The residues Arg158 and Asn164 of PCSK5 were crucial for its function. Semaglutide increased vascular densities and cardiac function post-MI, partially through EC-derived Pcsk5 in male mice. This study identified PCSK5 as a pro-angiogenic factor secreted by ECs, with the potential to become a therapeutic target for ischemic diseases.